Lee Gary's most recent trade in Lyell Immunopharma Inc was a trade of 8,000 Common Stock done . Disclosure was reported to the exchange on Aug. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2025 | 8,000 | 16,957 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 20 Aug 2025 | 1,453 | 15,504 | - | 10.5 | 15,320 | Common Stock |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 11 Aug 2025 | 136 | 8,957 | - | 10.3 | 1,406 | Common Stock |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 11 Aug 2025 | 131 | 9,093 | - | 10.5 | 1,379 | Common Stock |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 450,000 | 450,000 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 112,500 | 176,696 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 56,250 | 56,250 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Lyell Immunopharma Inc | Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 52,700 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Gary Lee | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 600,000 | 600,000 | - | - | Option (right to buy) |